(18928389), M. C. J., (22676472), G. A. R., (6887384), J. M. S., (783181), N. C., (22676475), M. C. T., & (22676478), L. M. N. (2025). Spearman correlation coefficient (r<sub>s</sub>) between echocardiographic measurements (i.e., left atrial: Aortic root diameter; LA:Ao), markers of loss of GI barrier function (i.e., lipopolysaccharide; LPS), and cardiac (i.e., troponin) and systemic (i.e., cytokines) inflammation in 36 dogs with untreated myxomatous mitral valve disease (MMVD).
Chicago-viite (17. p.)(18928389), Maria C. Jugan, Gabrielle A. Rands (22676472), Joerg M. Steiner (6887384), Natalia Cernicchiaro (783181), Matthew C. Tanner (22676475), ja Lillian M. Novotny (22676478). Spearman Correlation Coefficient (r<sub>s</sub>) Between Echocardiographic Measurements (i.e., Left Atrial: Aortic Root Diameter; LA:Ao), Markers of Loss of GI Barrier Function (i.e., Lipopolysaccharide; LPS), and Cardiac (i.e., Troponin) and Systemic (i.e., Cytokines) Inflammation in 36 Dogs with Untreated Myxomatous Mitral Valve Disease (MMVD). 2025.
MLA-viite (9. p.)(18928389), Maria C. Jugan, et al. Spearman Correlation Coefficient (r<sub>s</sub>) Between Echocardiographic Measurements (i.e., Left Atrial: Aortic Root Diameter; LA:Ao), Markers of Loss of GI Barrier Function (i.e., Lipopolysaccharide; LPS), and Cardiac (i.e., Troponin) and Systemic (i.e., Cytokines) Inflammation in 36 Dogs with Untreated Myxomatous Mitral Valve Disease (MMVD). 2025.